Basic Information
AESOMED, founded in August 2023, is the world's first biotechnology company to achieve large-scale production of recombinant exosomes. Within two years, the company has completed a full-chain breakthrough from technical validation to commercial export, becoming a pioneer among Chinese exosome companies expanding overseas.
--
Shanghai,China
unclear
March 22, 2023
--
--